In addition to reviewing clinical plans and study designs for Jerini's development projects, our Clinical Advisory Board also provides strategic advice to help us advance our drug candidates through the regulatory process.
 
Dr. Konrad Bork
Department of Dermatology, Johannes Gutenberg University, Mainz, Germany

Dr. Bertram Wiedenmann
Medical Faculty Charité, Humboldt University, Berlin, Germany